DACH1 a key protein for tumor suppression in ER+ breast cancer
Wednesday, July 15, 2009 - 11:28
in Health & Medicine
Researchers from the Kimmel Cancer Center at Jefferson have identified a protein relationship that may be an ideal treatment target for ER+ breast cancer. The study was reported in the July 15 issue of Cancer Research.